We used to think that Alzheimers disease was a problem with the production of too much amyloid-beta, but its become clear in recent years that the problem is with faulty clearance of amyloid-beta, said Zlokovic, professor of Neurosurgery and Neurology and director of the Frank P. Smith Laboratory for Neuroscience and Neurosurgery Research. We arent really talking about massive amounts of amyloid-beta. Even a small malfunction in the elaborate system that carries it into or out of the brain could lead, over years, to accumulate in amounts that damage the brain.
| Contact: Tom Rickey tom_rickey@urmc.rochester.edu 585-275-7954 University of Rochester Medical Center Source:Eurekalert |